Celyad competitorsClear all

Celyad's top competitors include Bellicum Pharmaceuticals, Alnylam Pharmaceuticals, Sorrento Therapeutics and Moderna.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Moderna
Moderna
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Founding Date
Founding Date
2007
Founding Date
2004
Founding Date
2002
Founding Date
2006
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Locations
San Diego, US HQ
San Diego, US
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Employees
Employees
8717% decrease
Employees
10738% decrease
Employees
1,32324% increase
Employees
31019% decrease
Employees
8309% increase
Valuation ($)
Valuation ($)
73 m
Valuation ($)
17.4 m
Valuation ($)
23.3 b
Valuation ($)
1.9 b
Valuation ($)
131.1 b
Twitter followers
Twitter followers
2.4 k
Twitter followers
571
Twitter followers
14.4 k
Twitter followers
N/A
Twitter followers
132.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
36
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
122.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
275697
Alexa Website Rank
178112
Alexa Website Rank
347064
Alexa Website Rank
210216
Alexa Website Rank
67329
Employee Rating
Employee Rating
3.7
Employee Rating
2.7
Employee Rating
4.2
Employee Rating
3.4
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
€3.5m (FY, 2017)
Revenue (est.)
$500k (FY, 2020)
Revenue (est.)
$492.9m (FY, 2020)
Revenue (est.)
$40m (FY, 2020)
Revenue (est.)
$803.4m (FY, 2020)
Cost of goods
Cost of goods
€515k (FY, 2017)
Cost of goods
N/A
Cost of goods
$78.1m (FY, 2020)
Cost of goods
N/A
Cost of goods
$7.9m (FY, 2020)
Gross profit
Gross profit
€3m (FY, 2017)
Gross profit
N/A
Gross profit
$414.8m (FY, 2020)
Gross profit
N/A
Gross profit
$795.5m (FY, 2020)
Net income
Net income
(€56.4m) (FY, 2017)
Net income
($7.7m) (FY, 2020)
Net income
($858.3m) (FY, 2020)
Net income
($314.4m) (FY, 2020)
Net income
($747.1m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.5b
Total funding raised
$ 42.6m
Total funding raised
$ 1.8b
For sources of this data, please see the company profile

View company profiles

Bellicum Pharmaceuticals
HQ
Houston, US
Employees
107↓ 38% decrease

Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company
Moderna
HQ
Cambridge, US
Employees
830↑ 9% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company